153 related articles for article (PubMed ID: 12749060)
1. Angelman syndrome associated with oculocutaneous albinism due to an intragenic deletion of the P gene.
Fridman C; Hosomi N; Varela MC; Souza AH; Fukai K; Koiffmann CP
Am J Med Genet A; 2003 Jun; 119A(2):180-3. PubMed ID: 12749060
[TBL] [Abstract][Full Text] [Related]
2. The mouse pink-eyed dilution gene: association with hypopigmentation in Prader-Willi and Angelman syndromes and with human OCA2.
Brilliant MH; King R; Francke U; Schuffenhauer S; Meitinger T; Gardner JM; Durham-Pierre D; Nakatsu Y
Pigment Cell Res; 1994 Dec; 7(6):398-402. PubMed ID: 7761348
[TBL] [Abstract][Full Text] [Related]
3. Angelman syndrome and severe infections in a patient with de novo 15q11.2-q13.1 deletion and maternally inherited 2q21.3 microdeletion.
Neubert G; von Au K; Drossel K; Tzschach A; Horn D; Nickel R; Kaindl AM
Gene; 2013 Jan; 512(2):453-5. PubMed ID: 23124039
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.
Lee ST; Nicholls RD; Bundey S; Laxova R; Musarella M; Spritz RA
N Engl J Med; 1994 Feb; 330(8):529-34. PubMed ID: 8302318
[TBL] [Abstract][Full Text] [Related]
5. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment.
Murthy SK; Nygren AO; El Shakankiry HM; Schouten JP; Al Khayat AI; Ridha A; Al Ali MT
Cytogenet Genome Res; 2007; 116(1-2):135-40. PubMed ID: 17268193
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic differences in Angelman syndrome patients: imprinting mutations show less frequently microcephaly and hypopigmentation than deletions.
Bürger J; Kunze J; Sperling K; Reis A
Am J Med Genet; 1996 Dec; 66(2):221-6. PubMed ID: 8958335
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic variability in Angelman syndrome: comparison among different deletion classes and between deletion and UPD subjects.
Varela MC; Kok F; Otto PA; Koiffmann CP
Eur J Hum Genet; 2004 Dec; 12(12):987-92. PubMed ID: 15470370
[TBL] [Abstract][Full Text] [Related]
8. Albinism and developmental delay: the need to test for 15q11-q13 deletion.
Saadeh R; Lisi EC; Batista DA; McIntosh I; Hoover-Fong JE
Pediatr Neurol; 2007 Oct; 37(4):299-302. PubMed ID: 17903679
[TBL] [Abstract][Full Text] [Related]
9. Clinical spectrum and molecular diagnosis of Angelman and Prader-Willi syndrome patients with an imprinting mutation.
Saitoh S; Buiting K; Cassidy SB; Conroy JM; Driscoll DJ; Gabriel JM; Gillessen-Kaesbach G; Glenn CC; Greenswag LR; Horsthemke B; Kondo I; Kuwajima K; Niikawa N; Rogan PK; Schwartz S; Seip J; Williams CA; Nicholls RD
Am J Med Genet; 1997 Jan; 68(2):195-206. PubMed ID: 9028458
[TBL] [Abstract][Full Text] [Related]
10. Influence of the Prader-Willi syndrome imprinting center on the DNA methylation landscape in the mouse brain.
Brant JO; Riva A; Resnick JL; Yang TP
Epigenetics; 2014 Nov; 9(11):1540-56. PubMed ID: 25482058
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and molecular genetic analysis of Angelman syndrome with oculocutaneous albinism type 2: A case report and literature review].
Zhou QJ; Gong P; Jiao XR; Yang ZX
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):181-185. PubMed ID: 36718709
[TBL] [Abstract][Full Text] [Related]
12. Familial interstitial 570 kbp deletion of the UBE3A gene region causing Angelman syndrome but not Prader-Willi syndrome.
Bürger J; Horn D; Tönnies H; Neitzel H; Reis A
Am J Med Genet; 2002 Aug; 111(3):233-7. PubMed ID: 12210318
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of imprinting of the Prader-Willi/Angelman region.
Horsthemke B; Wagstaff J
Am J Med Genet A; 2008 Aug; 146A(16):2041-52. PubMed ID: 18627066
[TBL] [Abstract][Full Text] [Related]
14. Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons.
Chai JH; Locke DP; Greally JM; Knoll JH; Ohta T; Dunai J; Yavor A; Eichler EE; Nicholls RD
Am J Hum Genet; 2003 Oct; 73(4):898-925. PubMed ID: 14508708
[TBL] [Abstract][Full Text] [Related]
15. Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes.
Glenn CC; Driscoll DJ; Yang TP; Nicholls RD
Mol Hum Reprod; 1997 Apr; 3(4):321-32. PubMed ID: 9237260
[TBL] [Abstract][Full Text] [Related]
16. Angelman Syndrome due to a Maternally Inherited Intragenic Deletion Encompassing Exons 7 and 8 of the UBE3A Gene.
Ververi A; Islam L; Bewes B; Busby L; Sullivan C; Canham N
Cytogenet Genome Res; 2017; 152(3):132-136. PubMed ID: 28898887
[TBL] [Abstract][Full Text] [Related]
17. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism.
Rinchik EM; Bultman SJ; Horsthemke B; Lee ST; Strunk KM; Spritz RA; Avidano KM; Jong MT; Nicholls RD
Nature; 1993 Jan; 361(6407):72-6. PubMed ID: 8421497
[TBL] [Abstract][Full Text] [Related]
18. Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele.
Spritz RA; Bailin T; Nicholls RD; Lee ST; Park SK; Mascari MJ; Butler MG
Am J Med Genet; 1997 Jul; 71(1):57-62. PubMed ID: 9215770
[TBL] [Abstract][Full Text] [Related]
19. Imprinted segments in the human genome: different DNA methylation patterns in the Prader-Willi/Angelman syndrome region as determined by the genomic sequencing method.
Zeschnigk M; Schmitz B; Dittrich B; Buiting K; Horsthemke B; Doerfler W
Hum Mol Genet; 1997 Mar; 6(3):387-95. PubMed ID: 9147641
[TBL] [Abstract][Full Text] [Related]
20. Imprinting center analysis in Prader-Willi and Angelman syndrome patients with typical and atypical phenotypes.
Camprubí C; Coll MD; Villatoro S; Gabau E; Kamli A; Martínez MJ; Poyatos D; Guitart M
Eur J Med Genet; 2007; 50(1):11-20. PubMed ID: 17095305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
